These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16160467)

  • 1. Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases.
    Sheikh HA; Sasatomi E; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Oct; 29(10):1267-73. PubMed ID: 16160467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma.
    Sasatomi E; Johnson LR; Aldeeb DN; Lomago DM; Thompson JW; Swalsky PA; Luketich JD; Fernando HC; Finkelstein SD; Yousem SA
    Am J Surg Pathol; 2004 Oct; 28(10):1280-8. PubMed ID: 15371943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa.
    Ozolek JA; Hunt JL
    Am J Surg Pathol; 2006 Dec; 30(12):1576-80. PubMed ID: 17122514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
    Yoshioka H; Takeuchi T; Matsuno Y; Yamada T; Shimosato Y; Hirohashi S; Noguchi M
    Jpn J Clin Oncol; 1998 Apr; 28(4):240-4. PubMed ID: 9657008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes in contralateral bronchioloalveolar carcinomas of the lung.
    Shin SW; Breathnach OS; Linnoila RI; Williams J; Gillespie JW; Kelley MJ; Johnson BE
    Oncology; 2001; 60(1):81-7. PubMed ID: 11150913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease.
    Holst VA; Finkelstein S; Yousem SA
    Am J Surg Pathol; 1998 Nov; 22(11):1343-50. PubMed ID: 9808126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
    Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
    Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
    Dacic S; Finkelstein SD; Yousem SA
    Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma.
    Matsumoto S; Iwakawa R; Kohno T; Suzuki K; Matsuno Y; Yamamoto S; Noguchi M; Shimizu E; Yokota J
    Int J Cancer; 2006 May; 118(10):2498-504. PubMed ID: 16353158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.
    Aoyagi Y; Yokose T; Minami Y; Ochiai A; Iijima T; Morishita Y; Oda T; Fukao K; Noguchi M
    Cancer Res; 2001 Nov; 61(21):7950-4. PubMed ID: 11691817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.
    Suzuki K; Ogura T; Yokose T; Nagai K; Mukai K; Kodama T; Nishiwaki Y; Esumi H
    Int J Cancer; 1998 Aug; 79(4):384-9. PubMed ID: 9699531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.
    Iijima H; Tomizawa Y; Dobashi K; Saito R; Nakajima T; Mori M
    Br J Cancer; 2004 Sep; 91(6):1143-8. PubMed ID: 15292942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
    Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
    Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.